Lista de obras - Louise Johnson - Dominio Público Uruguay

4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2.

artículo científico publicado en 2003

Alternative binding modes of an inhibitor to two different kinases

artículo científico publicado en 2003

CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?

artículo científico publicado en 2005

Cyclin B and cyclin A confer different substrate recognition properties on CDK2

artículo científico publicado en 2007

Early days of structural biology

artículo científico publicado en 2008

Exploiting structural principles to design cyclin-dependent kinase inhibitors.

artículo científico publicado en 2005

Glucofuranose analogues of hydantocidin

Halogen bonds form the basis for selective P-TEFb inhibition by DRB

artículo científico publicado en 2010

Introducing Open Biology

artículo científico publicado en 2011

Phototransformation of green fluorescent protein with UV and visible light leads to decarboxylation of glutamate 222

artículo científico publicado el 1 de enero de 2002

Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP).

artículo científico publicado en 2008

Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives

artículo científico publicado en 2002

Protein kinase inhibitors: contributions from structure to clinical compounds

artículo científico publicado en 2009

Protein kinase inhibitors: insights into drug design from structure.

artículo científico publicado en 2004

Recognition of Cdk2 by Cdk7

scientific article published on 01 June 2007

Simulation of diffusion time of small molecules in protein crystals

artículo científico publicado en 2006

Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A

artículo científico publicado en 2002

Structural analysis of the anaphase-promoting complex reveals multiple active sites and insights into polyubiquitylation

artículo científico publicado en 2005

Structural and functional studies of the response regulator HupR.

artículo científico publicado en 2006

Structural characterization of Ca2+/CaM in complex with the phosphorylase kinase PhK5 peptide

artículo científico publicado en 2005

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

artículo científico publicado en 2002

Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase

artículo científico publicado en 2008

Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor

artículo científico publicado en 2002

Structure-based design of cyclin-dependent kinase inhibitors

artículo científico publicado en 2002

Structures of the Dsk2 UBL and UBA domains and their complex

artículo científico publicado en 2006

Substrates of Mitotic Kinases ⬇️

artículo científico publicado el 28 de junio de 2011

The HupR receiver domain crystal structure in its nonphospho and inhibitory phospho states

artículo científico publicado en 2009

The binding of flavopiridol to blood serum albumin

artículo científico publicado en 2010

The crystal structure of human CDK7 and its protein recognition properties

artículo científico publicado en 2004

The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex

artículo científico publicado en 2003

The regulation of protein phosphorylation

artículo científico publicado en 2009

The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition

artículo científico publicado en 2006

The structural basis for control of eukaryotic protein kinases

artículo científico

The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation

artículo científico publicado en 2008

The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles

artículo científico publicado en 2005

The structure of phosphorylase kinase holoenzyme at 9.9 angstroms resolution and location of the catalytic subunit and the substrate glycogen phosphorylase

artículo científico publicado en 2009

Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b

artículo científico publicado en 2002

Two different conformational states of the KirBac3.1 potassium channel revealed by electron crystallography.

artículo científico publicado en 2005

Lista de obras de Louise Johnson

4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2.

Alternative binding modes of an inhibitor to two different kinases

CAK-Cyclin-dependent Activating Kinase: a key kinase in cell cycle control and a target for drugs?

Cyclin B and cyclin A confer different substrate recognition properties on CDK2

Early days of structural biology

Exploiting structural principles to design cyclin-dependent kinase inhibitors.

Glucofuranose analogues of hydantocidin

Halogen bonds form the basis for selective P-TEFb inhibition by DRB

Introducing Open Biology

Phototransformation of green fluorescent protein with UV and visible light leads to decarboxylation of glutamate 222

Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP).

Probing the ATP ribose-binding domain of cyclin-dependent kinases 1 and 2 with O(6)-substituted guanine derivatives

Protein kinase inhibitors: contributions from structure to clinical compounds

Protein kinase inhibitors: insights into drug design from structure.

Recognition of Cdk2 by Cdk7

Simulation of diffusion time of small molecules in protein crystals

Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A

Structural analysis of the anaphase-promoting complex reveals multiple active sites and insights into polyubiquitylation

Structural and functional studies of the response regulator HupR.

Structural characterization of Ca2+/CaM in complex with the phosphorylase kinase PhK5 peptide

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2.

Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase

Structure-based design of a potent purine-based cyclin-dependent kinase inhibitor

Structure-based design of cyclin-dependent kinase inhibitors

Structures of the Dsk2 UBL and UBA domains and their complex

Substrates of Mitotic Kinases ⬇️

The HupR receiver domain crystal structure in its nonphospho and inhibitory phospho states

The binding of flavopiridol to blood serum albumin

The crystal structure of human CDK7 and its protein recognition properties

The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex

The regulation of protein phosphorylation

The role of the phospho-CDK2/cyclin A recruitment site in substrate recognition

The structural basis for control of eukaryotic protein kinases

The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation

The structure of cyclin E1/CDK2: implications for CDK2 activation and CDK2-independent roles

The structure of phosphorylase kinase holoenzyme at 9.9 angstroms resolution and location of the catalytic subunit and the substrate glycogen phosphorylase

Three-dimensional structure of phosphorylase kinase at 22 A resolution and its complex with glycogen phosphorylase b

Two different conformational states of the KirBac3.1 potassium channel revealed by electron crystallography.